- Staat
- MD
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 21.03.2022
- Impfdatum
- 21.03.2022
- Beginn
- 21.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- SC / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Presyncope
Symptomtext
Vasovagal bout 10 seconds and lied on exam bed. No injury and was oriented.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Presyncope
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- no
- Vorgeschichte
- no
- Andere Medikamente
- no
- Allergien
- n
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 1,4
- Geschlecht
- F
- Eingang
- 18.02.2023
- Impfdatum
- 15.02.2023
- Beginn
- 15.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SC / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Crying
Erythema
Flushing
Injection site urticaria
Irritability
Papule
Symptomtext
Per mother and MA's report, patient developed a wheal on R thigh immediately following immunization administration, as well as scattered erythematous papules on face. Patient was reevaluated by myself following vaccine administration, patient was irritable on assessment until breastfeeding was initiated. No evidence of respiratory distress or swelling was noted on reassessment. Patient did have a few scattered mildly erythematous papules in perioral distribution. Was generally flushed due to crying. One dose Benadryl 6.25mg was administered in office. Patient reevaluated following Benadryl administration. Facial erythema appeared to be resolving. Patient was active and well appearing.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site urticaria
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Milk protein intolerance
- Andere Medikamente
- Albuterol PRN
- Allergien
- Milk, lactose
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 05.01.2022
- Impfdatum
- 15.12.2021
- Beginn
- 17.12.2021
- Tage bis Beginn
- 2,0
- Dosis
- 2
- Route/Site
- SC / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Decreased appetite
Hallucination
Influenza virus test negative
Lethargy
Pyrexia
SARS-CoV-2 test negative
Streptococcus test negative
Symptomtext
Two days after receiving vaccinations on 12/15/2021, parent of patient reported a high fever (103 degrees and fatigue). After further testing (covid, strep and flu) at the Emergency Department all tests were negative. Patient came in office on 1/4/22 with reports of high fevers (104) on and off with hallucinations that occur with and without fevers present. Patient was also lethargic and decreased appetite. All tests in the clinic were negative at office visit on 1/4/22. Provider ordered further labs and neurology referral.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pyrexia
- Hospital-Tage
- -
- Labordaten
- COVID, STREP, FLU- 12/21/2021 (negative); COVID- 1/4/2022 (negative)
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- -
- Geschlecht
- U
- Eingang
- 31.08.2023
- Impfdatum
- 07.08.2023
- Beginn
- 07.08.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Patient involved do not experiencing symptoms at this time; Medical Assistant calling to report administration of expired VARIVAX.; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 07-AUG-2023, the patient was vaccinated with an expired dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 0.5 ml, two doses series, lot #U022321, expiration date: 15-JUL-2023, administered for prophylaxis (strength, and route of administration were not provided). Patient involved did not experience symptoms at this time.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- ME
- Alter
- 4,0
- Geschlecht
- F
- Eingang
- 01.06.2023
- Impfdatum
- 01.06.2023
- Beginn
- 01.06.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
Symptomtext
Patient was given ProQuad and Varivax.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 1,0
- Geschlecht
- F
- Eingang
- 22.09.2022
- Impfdatum
- 13.09.2022
- Beginn
- 13.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Accidental overdose
Extra dose administered
No adverse event
Symptomtext
No other adverse event; Caller is a nurse who reports inadvertent concomitant administration of PROQUAD and VARIVAX to a 12-month-old female patient. Patient did not have any symptoms or adverse effects from administration. No further information provided; no other AE/no PQ; This spontaneous report was received from a licensed practical nurse concerning a 12-month-old female patient. The patient's medical history, historical drugs and concurrent conditions were not reported. On 13-SEP-2022, the patient was inadvertently vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD) subcutaneous injection, 0.5 milliliter, lot #U017140, expiration date: 28-NOV-2022 (strength, and route of administration were not provided); and varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 0.5 milliliter, lot #U022321, expiration date: 15-JUL-2023 (strength, and route of administration were not provided), both administered concomitantly as prophylaxis (accidental overdose), in combination with 0.7 ml of sterile diluent, lot #T001632, expiration date 01-SEP-2023. The patient did no have any symptoms or adverse effects from administration.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Accidental overdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- STERILE DILUENT
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- -
- Geschlecht
- U
- Eingang
- 16.07.2022
- Impfdatum
- 25.05.2022
- Beginn
- 25.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
no adverse event; administered after temperature excursion; This spontaneous report was received from an administrator referring to a patient of unknown age and gender. Concomitant medication, pertinent medical history, concurrent condition and drug reactions/allergies were not reported. On 25-MAY-2022, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 ml subcutaneously (SQ) for prophylaxis (lot # U022321, expiration date: 15-JUL-2023; strength was not provided) after a temperature excursion (temperature: 6 Fahrenheit (F); time frame: 30 minutes) (product storage error). There was no previous temperature excursion. No additional adverse event was reported (no adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- -
- Geschlecht
- U
- Eingang
- 15.07.2022
- Impfdatum
- 16.06.2022
- Beginn
- 16.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No adverse event; VARIVAX administered after temperature excursion; This spontaneous report was received from an administrator referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions drug reactions/allergies and concomitant therapies were not reported. On 16-JUN-2022, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) after temperature excursion (product storage error), 0.5 milliliter, lot #U022321 with expiration date: 15-JUL-2023, administered subcutaneously (SQ) as prophylaxis (strength was not provided). The vaccine underwent temperature excursion of 6 Fahrenheit for 30 minutes. It did not have previous temperature excursion. No additional adverse events were reported (no adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- -
- Geschlecht
- U
- Eingang
- 15.07.2022
- Impfdatum
- 02.05.2022
- Beginn
- 02.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AEs; VARIVAX administered after temperature excursion; This spontaneous report was received from an administrator and referred to a patient of unknown gender and age. The patient's concomitant medications, pertinent medical history, and drug reactions/allergies were not reported. On 02-MAY-2022, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 milliliter subcutaneously (valid lot #U022321 with an expiration date: 15-JUL-2023) for prophylaxis. The vaccine was administered after temperature excursion, temperature 6 Fahrenheit with a time frame of 30 mins (product storage error). There was no previous temperature excursion. No additional adverse events were reported (no adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- -
- Geschlecht
- U
- Eingang
- 15.07.2022
- Impfdatum
- 13.05.2022
- Beginn
- 13.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
No additional adverse events; Caller reported VARIVAX administered after temperature excursion; This spontaneous report was received from an administrator and refers to a patient of unknown age and gender. There was no information regarding the patient's medical history, concurrent conditions and concomitant medications provided. On 13-MAY-2022, the patient was vaccinated with an improperly stored varicella virus vaccine live (Oka/Merck) (VARIVAX) at a dose of 0.5 ml, subcutaneously, lot # U022321 confirmed to be valid with an expiration date: 15-JUL-2023 (anatomical location was not reported) for prophylaxis. The vaccine underwent a temperature excursion of 6 degrees Fahrenheit for 30 minutes (product storage error). There was no previous temperature excursion. No additional adverse event was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 1,0
- Geschlecht
- M
- Eingang
- 14.07.2022
- Impfdatum
- 12.07.2022
- Beginn
- 12.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- SC / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
No adverse event
Symptomtext
2 Varicella given by error. 1 MMR w/ Varicella and 1 Varicella. on the same day. Pt. was checked on the next day by nurse and there were no adverse events at this time. Also, reporter to Dr. and he had no cause for concerns.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- 6/16/2022 Conjunctivitis of both eyes
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- -
- Geschlecht
- U
- Eingang
- 08.07.2022
- Impfdatum
- 16.05.2022
- Beginn
- 16.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AEs or PQC reported.; Caller reported VARIVAX administered after temperature excursion.; This spontaneous information has been received from an administrator, concerning a male patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, previously drug reactions, allergies and concomitant medications were not provided. On 16-MAY-2022, the patient was vaccinated with varicella virus vaccine live (Oka/Merck) (VARIVAX) subcutaneous injection at dose of 0.5 milliliter (ml) subcutaneously (SQ), with lot number U022321 and expiration date 15-JUL-2023, for prophylaxis (vaccination scheme frequency and anatomical location was not provided). This administration was performed after a temperature excursion (product storage error), with a temperature of 6 degrees Fahrenheit (F), time frame 30 minutes; it was reported that there was no previous temperature excursion. No adverse events were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- -
- Geschlecht
- U
- Eingang
- 07.07.2022
- Impfdatum
- 28.04.2022
- Beginn
- 28.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AEs or PQC reported.; VARIVAX administered after temperature excursion; This spontaneous report was received from an administrator and refers to a patient of unknown age and gender. No information regarding the patient's medical history, concurrent conditions or concomitant medications was provided. On 28-APR-2022, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) 0.5 milliliter, subcutaneously, lot # U022321 was confirmed to be valid with expiration date 15-JUL-2023 for prophylaxis (site of administration was not reported). The administered dose was exposed to the temperature of 6 degrees Fahrenheit for 30 minutes. There was no previous temperature excursion. No additional adverse events were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- -
- Geschlecht
- U
- Eingang
- 03.07.2022
- Impfdatum
- 17.05.2022
- Beginn
- 17.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AEs or PQC reported; Caller reported VARIVAX administered after temperature excursion.; This spontaneous report was received from an administrator referring to a patient of unknown age and gender. The patient's medical history, historical drugs, concurrent conditions and concomitant medications were not provided. On 17-MAY-2022, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) 0.5 milliliter, subcutaneous, lot number U022321, expiration date 15-JUL-2023 for prophylaxis (product storage error). No adverse event was reported. The excursion was of 6 degrees Farhrenheit for 30 minutes. No previous temperature excursions were detected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- -
- Geschlecht
- U
- Eingang
- 03.07.2022
- Impfdatum
- 22.04.2022
- Beginn
- 22.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AEs or PQC.; Caller reported VARIVAX administered after temperature excursion. Names of vaccines involved (including lot/exp) VARIVAX U022321 7/15/2023. Temperature 6F. Time frame 30 min; This spontaneous report has been received from an administrator referring a patient of an unknown age and gender. The patient's pertinent medical history, concurrent conditions, drug reactions or allergies and concomitant medications were not provided. On 22-APR-2022, the patient was vaccinated with improperly stored dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) at dose 0.5 ml, subcutaneously, lot number U022321, expiration date on 15-JUL-2023 for prophylaxis (strength and frequency were not reported) that underwent a temperature excursion of 6 Fahrenheit degrees for 30 minutes (product storage error). There was no previous temperature excursion. No additional adverse events were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- -
- Geschlecht
- U
- Eingang
- 27.06.2022
- Impfdatum
- 04.05.2022
- Beginn
- 04.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No adverse event; Caller reported VARIVAX administered after temperature excursion.; This spontaneous report has been received from a physician referring a patient of unknown age and gender. The patient's pertinent historical condition, concurrent condition, drug reactions/allergies or concomitant medication was not provided. On 04-MAY-2022, the patient was vaccinated with varicella virus vaccine live (Oka/Merck) (VARIVAX) at dose 0.5 milliliter (ML), via subcutaneous (SQ), (lot number U022321, expiration date 15-JUL-2023) for prophylaxis (strength and frequency were not reported) that after temperature excursion 6 Fahrenheit (F) for 30 minutes (product storage error).There was no previous temperature excursion. No additional adverse events were reported (no adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- -
- Geschlecht
- U
- Eingang
- 25.06.2022
- Impfdatum
- 09.05.2022
- Beginn
- 09.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No Adverse event; Caller reported VARIVAX administered after temperature excursion.; This spontaneous report was received on 16-JUN-2022 from an administrator regarding a patient of unknown age or gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On an unspecified date, the vaccine varicella virus vaccine live (oka/merck) (VARIVAX) (lot #U022321, expiration date: 15-JUL-2023) was stored at an inappropriate temperature of 6F for a time frame of 30 minutes. The was no previous temperature excursion. On 09-MAY-2022, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 0.5 milliliter (lot #U022321, expiration date: 15-JUL-2023) administered subcutaneously for prophylaxis (strength was not provided). No adverse events were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- -
- Geschlecht
- U
- Eingang
- 22.06.2022
- Impfdatum
- 10.05.2022
- Beginn
- 10.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AEs or PQC reported; Caller reported VARIVAX administered after temperature excursion.; This spontaneous report was received from an administrator and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 10-MAY-2022, the patient was vaccinated with an inappropriate stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 0.5 milliliter, lot #U022321, expiration date: 15-JUL-2023, administered subcutaneously for prophylaxis (strength was not provided). Temperature 6F Time frame 30 Minutes Previous temperature excursion? No No adverse events were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- -
- Geschlecht
- U
- Eingang
- 22.06.2022
- Impfdatum
- 28.04.2022
- Beginn
- 28.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
No additional AEs; VARIVAX administered after temperature excursion; This spontaneous report was received from an administrator referring to a patient of unknown age and gender. No information was provided regarding the patient's medical history, concurrent conditions, drug reactions or allergies and concomitant medication. On 28-APR-2022, the patient was vaccinated with a dose of varicella virus vaccine live (oka/merck)(VARIVAX) after temperature excursion, lot number U022321 and expiration date of 15-JUL-2023 00:00, at a dose of 0.5 milliliter, subcutaneously for prophylaxis (anatomical location was not reported). The vaccine was exposed to a temperature excursion of 6?F with a time frame of 30 minutes. There was no previous temperature excursion. No additional adverse events were reported. There was not product quality complaint involved.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Prophylaxis
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- -
- Geschlecht
- U
- Eingang
- 21.06.2022
- Impfdatum
- 20.05.2022
- Beginn
- 20.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AEs; Caller reported VARIVAX administered after temperature excursion.; This spontaneous report was received from an administrator and refers to patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported. There was no information regarding the patient's allergies or drug reactions. On 20-MAY-2022, the patient was vaccinated with a dose of improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) 0,5 ml, administered subcutaneously, lot #U022321, expiration date: 15-JUL-2023, (strength and anatomical location were not provided) for prophylaxis (product storage error). No additional adverse events was provided (no adverse event). For varicella virus vaccine live (oka/merck) (VARIVAX), temperature excursion was reported as 6 Fahrenheit (F) degrees for 30 minutes. There was no previous temperature excursion reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 03.06.2022
- Impfdatum
- 27.05.2022
- Beginn
- 27.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- SYR / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
The medication was expired.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- None, Pt did not experience any adverse effects from the medication.
- Aktuelle Erkrankungen
- no
- Vorgeschichte
- no
- Andere Medikamente
- no
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 2,3
- Geschlecht
- F
- Eingang
- 26.04.2022
- Impfdatum
- 22.04.2022
- Beginn
- 22.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SC / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Wrong product administered
Symptomtext
Pt was accidently given two doses of DTAP on 4/22/22. She was supposed to receive Hep A, Pentacel, PCV13, MMR, Varicella. CDC state vaccine unit & Regional Imm nurse notified. Parent was notified and advised what s/s to look for and advised to f/u with our office for any side effects / concerns.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- none known
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 0,8
- Geschlecht
- F
- Eingang
- 12.04.2022
- Impfdatum
- 11.03.2022
- Beginn
- 11.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Inappropriate schedule of product administration
Product administered to patient of inappropriate age
Symptomtext
Vaccines were given to soon. Child was under 12 months of age
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 1,0
- Geschlecht
- F
- Eingang
- 28.03.2022
- Impfdatum
- 28.03.2022
- Beginn
- 28.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- SC / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Symptomtext
Administered ProQuad and Varivax, pt did not have any adverse event or reaction.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- none.
- Aktuelle Erkrankungen
- None.
- Vorgeschichte
- none.
- Andere Medikamente
- None.
- Allergien
- None.
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 1,0
- Geschlecht
- U
- Eingang
- 24.03.2022
- Impfdatum
- 04.03.2022
- Beginn
- 04.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AEs were reported; a patient received improperly stored vaccine; This spontaneous report has been received from a medical assistant referring to a 12-month-old patient of unspecified age. The patient's pertinent medical history, concomitant medications, and previous drug reactions or allergies were not reported. On 04-MAR-2022, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 milliliters (ml) once (route of administration, anatomical site of vaccination, and vaccine scheme were not reported; lot number U022321 has been verified to be valid, expiration date reported and established as 15-JUL-2023) as prophylaxis. The vaccine was exposed to a temperature excursion of minus 8.1 degrees Celsius during a time frame of 4 hours (product storage error). There was not a previous temperature excursion and no additional adverse events were reported (no adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- -
- Geschlecht
- U
- Eingang
- 11.03.2022
- Impfdatum
- 05.03.2022
- Beginn
- 05.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AEs were reported; a patient received improperly stored vaccine; This spontaneous report was received from a medical assistant referring to a 12-month-old patient. The patient's medical history, historical drugs, concurrent conditions and concomitant medications were not provided. On 05-MAR-2022, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) 0.5 milliliter, once, lot number U022321, expiration date 15-JUL-2023 for prophylaxis (route of administration not reported) No adverse event was reported. The vaccine underwent a temperature excursion of -8.1 degrees Celsius for 4 hours. No previous temperature excursions were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- VA
- Alter
- 14,0
- Geschlecht
- F
- Eingang
- 01.03.2022
- Impfdatum
- 01.03.2022
- Beginn
- 01.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SC / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Symptomtext
Pt given MMRV (Proquad) and Varicella (Varivax) in same visit. No reaction after 15 min observation. Advised to monitor for anaphylaxis symptoms or seizures and go to nearest emergency hospital and notify the health department after discharge.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- no drug allergies, no allergies to any previous vaccines, no food allergies
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- -
- Geschlecht
- U
- Eingang
- 26.02.2022
- Impfdatum
- 19.01.2022
- Beginn
- 19.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
No additional AE; The vaccine was administerd after a temperature excursion/Temperature: -14.1 degree Celsius, time frame: 12 minutes.; This spontaneous report was received from a nurse, referring to a patient of unknown age and gender. No information regarding the patient's concurrent conditions, medical history and concomitant medications was provided. On 19-JAN-2022, the patient was vaccinated with improperly stored (temperature: -14.1 degree Celsius, time frame: 12 minutes) varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 ml, lot #: U022321, expiration date: 15-JUL-2023 (strength, site and route of administration were not provided) for prophylaxis (product storage error). There was no additional adverse event reported (No adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- -
- Geschlecht
- U
- Eingang
- 26.02.2022
- Impfdatum
- 18.01.2022
- Beginn
- 18.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
No additional AE; The vaccine was administered after a temperature excursion/ Temperature: -14.1 degree Celsius, time frame: 12 minutes; This spontaneous report was received from a nurse, referring to a patient of unknown age and gender. No information regarding the patient's concurrent conditions, medical history and concomitant medications was provided. On 18-JAN-2022, the patient was vaccinated with improperly stored (temperature: -14.1 degree Celsius, timeframe: 12 minutes) varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 ml, lot #: U022321, expiration date: 15-JUL-2023 (strength, site and route of administration were not provided) for prophylaxis (product storage error). There was no additional adverse event reported (No adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- -
- Geschlecht
- U
- Eingang
- 26.02.2022
- Impfdatum
- 20.01.2022
- Beginn
- 20.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AE; the vaccine was administered after a temperature excursion; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. No information about the patient's medical history, concomitant medications and concurrent conditions was reported. On 20-JAN-2022, the patient was vaccinated with improperly stored (temperature -14.1 Celsius degrees, time frame: 12 minutes) varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 milliliter, lot #U022321, expiration date: 15-JUL-2023 (route of administration were not provided) for prophylaxis, (Product storage error). No additional adverse event was reported (no adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- -
- Geschlecht
- U
- Eingang
- 26.02.2022
- Impfdatum
- 21.01.2022
- Beginn
- 21.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AE; vaccine was administered after a temperature excursion; This spontaneous report as received from a nurse refers to a patient of unknown age and gender. No information regarding the patient's concurrent conditions, medical history, drug reactions or allergies and concomitant medications was provided. On 21-JAN-2022, the patient was vaccinated with dose of improperly stored varicella virus vaccine live (oka/merck)(VARIVAX) 0.5 mL, lot # U022321, expiration date: 15-JUL-2023 (route of administration was not reported) for prophylaxis. Administered dose of vaccine has been stored in the temperature of -14.1 degrees Celsius for 12 minutes. There were no previous temperature excursions reported. No adverse event was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- -
- Geschlecht
- U
- Eingang
- 26.02.2022
- Impfdatum
- 18.01.2022
- Beginn
- 18.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
no adverse event; vaccine was administered after a temperature excursion; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 18-JAN-2022, the patient started therapy with varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 0.5 milliliter, lot #U022321, expiration date: 15-JUL-2023, administered for prophylaxis (strength, and route of administration were not provided). The reported stated that the vaccine was improperly stored (temperature -14.1 Celsius degrees for 12 minutes). There was no previous temperature excursion. No adverse effects were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- -
- Geschlecht
- U
- Eingang
- 26.02.2022
- Impfdatum
- 18.01.2022
- Beginn
- 18.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
No additional AE; Caller stated the vaccine was administered after a temperature excursion; This spontaneous report was received from a nurse, referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, concomitant medications, previous drug reactions, or allergies were not reported. On 18-JAN-2022, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) injection, at a dose of 0.5 milliliter (ml) (strength, vaccination scheme, anatomical site of vaccination, and route of administration were not reported; lot number U022321, expiration date reported and validated as 15-JUL-2023) as prophylaxis, after a temperature excursion (product storage error). The vaccine experienced a temperature excursion of minus (-) 14.1 degrees Celsius (C) for 12 minutes. There was no previous temperature excursion.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- -
- Geschlecht
- U
- Eingang
- 21.02.2022
- Impfdatum
- 14.01.2022
- Beginn
- 14.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AE; The vaccine was administered after a temperature excursion/Temperature -14.1 degree Celsius, timeframe 12 minutes; This spontaneous report was received from a nurse, referring to a patient of unknown age and gender. No information regarding the patient's concurrent conditions, medical history and concomitant medications was provided. On 14-JAN-2022, the patient was vaccinated with improperly stored (temperature: -14.1 degree Celsius, timeframe: 12 minutes) varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 ml, lot #: U022321, expiration date: 15-JUL-2023 (strength, site and route of administration were not provided) for prophylaxis (product storage error).There was no additional adverse event (no adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- -
- Geschlecht
- U
- Eingang
- 21.02.2022
- Impfdatum
- 19.01.2022
- Beginn
- 19.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Symptomtext
No additional AE; Caller stated the vaccine was administered after a temperature excursion; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, medical history or concomitant therapy provided. On 19-JAN-2022, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 ml, lot # U022321, expiration date 15-JUL-2023 (route of administration and anatomical location were not provided) for prophylaxis (product storage error). The excursion time frame was 12 minutes and temperature was - 14.1 Celsius degrees. There was no previous excursions. No additional adverse event reported (no adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- -
- Geschlecht
- U
- Eingang
- 21.02.2022
- Impfdatum
- 20.01.2022
- Beginn
- 20.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AE; the vaccine was administered after a temperature excursion; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. No information regarding the patient's concurrent conditions, concomitant medications and medical history was provided. On 20-JAN-2022, the patient was vaccinated with 0.5 ml dose of varicella virus vaccine live (oka/merck)(VARIVAX), lot # U022321, expiration date: 15-JUL-2023, (dosing schedule and route of administration was not provided), for prophylaxis, which was administered after a temperature excursion. Administered dose of vaccine was exposed to the temperature -14.1 Celsius degrees for 12 minutes. No previous temperature excursion was noted. No additional adverse event reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- -
- Geschlecht
- U
- Eingang
- 21.02.2022
- Impfdatum
- 20.01.2022
- Beginn
- 20.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AE/No PQC; the vaccine was administered after a temperature excursion; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's concomitant medications, concurrent conditions, medical history and drug reactions/allergies were not reported. On 20-JAN-2022, the patient was administered with varicella virus vaccine live (Oka/Merck) (VARIVAX) 0.5 milliliter (lot # U022321, expiration date: 15-JUL-2023, strength and route were unknown) after a temperature excursion for prophylaxis (product storage error). The vaccine was exposed to minus 14.1 degrees Celsius for 12 minutes. There was no previous excursion. No additional adverse event was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- -
- Geschlecht
- U
- Eingang
- 11.02.2022
- Impfdatum
- 20.01.2022
- Beginn
- 20.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AE.; administered after a temperature excursion; This spontaneous report was received from a nurse and refers to a patient of an unknown age and gender. No information regarding the patient's pertinent medical history, concomitant medications and drug reactions or allergies was reported. On 20-JAN-2022, the patient was vaccinated with improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 0.5 milliliter, lot #U022321 was confirmed to be valid, expiration date: 15-JUL-2023, administered for prophylaxis (strength, and route of administration were not provided). The temperature excursion was - 14.1 Celsius degrees (C) (C) for 12 Minutes (Product storage error). There were no previous excursions reported. No adverse effects were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- -
- Geschlecht
- U
- Eingang
- 09.02.2022
- Impfdatum
- 21.01.2022
- Beginn
- 21.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AE.; the vaccine was administered after a temperature excursion.; Information has been received from a nurse referring to a patient of unknown age and gender. Information of concomitant therapy, pertinent medical history and drug reactions/allergies was not reported. On 21-JAN-2022, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck)(VARIVAX) (0.5 milliliter, lot # U022321, expiration date:15-JUL-2023, strength, frequency and route were unknown) for prophylaxis (incorrect product storage). No additional adverse event was reported. The stored temperature was -14.1 degree Celsius. The time frame was 12 minutes. There was no previous temperature excursion.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- -
- Geschlecht
- U
- Eingang
- 09.02.2022
- Impfdatum
- 14.01.2022
- Beginn
- 14.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AE; vaccine was administered after a temperature excursion; This spontaneous report was received from a nurse concerning a patient of unknown age and gender. Information on pertinent medical history, concomitant medications and drug reactions/allergies was not reported. On 14-JAN-2022, the patient was vaccinated with an improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) (lot # U022321, expiration date 15-JUL-2023) 0.5 milliliter for prophylaxis (dose number, route of administration and location of administration were not reported). The vaccine was exposed to a temperature of -14.1 C for 12 minutes. There were no previous temperature excursions. No adverse effects were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- -
- Geschlecht
- U
- Eingang
- 03.02.2022
- Impfdatum
- 18.01.2022
- Beginn
- 18.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AE; the vaccine was administered after a temperature excursion; This spontaneous report as received from a nurse refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions, allergies and concomitant therapies was provided. On 18-JAN-2022, after a temperature excursion, the patient was vaccinated with a varicella virus vaccine live (oka/merck) (VARIVAX), lot # U022321, expiry date 15-JUL-2023, 0.5 milliliter (route and site of administration were not reported) for prophylaxis. The administered dose of vaccine experienced the temperature excursion of -14.1 degrees Celsius for 12 minutes. There was no previous temperature excursion reported. No additional adverse event was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- -
- Geschlecht
- U
- Eingang
- 03.02.2022
- Impfdatum
- 14.01.2022
- Beginn
- 14.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AE; the vaccine was administered after a temperature excursion; This spontaneous report as received from a nurse refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions, allergies and concomitant therapies was provided. On 14-JAN-2022, after a temperature excursion, the patient was vaccinated with a varicella virus vaccine live (oka/merck) (VARIVAX), lot # U022321, expiry date 15-JUL-2023, 0.5 milliliter (route and site of administration were not reported) for prophylaxis. The administered dose of vaccine experienced the temperature excursion of -14.1 degrees Celsius for 12 minutes. There was no previous temperature excursion reported. No additional adverse event was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- -
- Geschlecht
- U
- Eingang
- 03.02.2022
- Impfdatum
- 20.01.2022
- Beginn
- 20.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
No additional AE; Caller stated the vaccine was administered after a temperature excursion; This spontaneous report has been from a nurse concerning to a patient of unknown age and gender. No information was provided regarding the patients' medical history, concurrent conditions, drug or allergy history. No concomitant therapies were reported. On 20-JAN-2022, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 0.5 milliliter,(lot #U022321 and expiration date since it makes match with the autopopulated expiration date 15-JUL-2023), (strength, route of administration, and indication were not provided), which where stored at temperature excursion. The temperature excursion was - 14 degree Celsius for a time frame of 12 minutes. There was not previous temperature excursion.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 26.01.2022
- Impfdatum
- 21.01.2022
- Beginn
- 21.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
No adverse event
Symptomtext
Expired varicella vaccine administered and was noted immediately. Patient was recalled and non expired dose of varicella was administered the same day. When patient was seen in follow up three days later, she was asymptomatic with no evidence of an adverse outcome
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 26.11.2021
- Impfdatum
- 25.11.2021
- Beginn
- 25.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Exposure during pregnancy
Product use issue
Symptomtext
Pregnant female immunized with Varivax and MMR vaccines
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Exposure during pregnancy
- Hospital-Tage
- -
- Labordaten
- Patient to be referred to OB/GYN for assessment of pregnancy and inappropriate vaccination
- Aktuelle Erkrankungen
- Scabies
- Vorgeschichte
- -
- Andere Medikamente
- Permetherin
- Allergien
- NKDA
- Vorherige Impfungen
- -